COMMUNIQUÉS West-GlobeNewswire

IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2026
08/06/2026
Aggregated presentation by day and by market Purchases of own shares from June 1st to June 5th 2026 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2026
08/06/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 1 er juin au 5 juin 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
GENFIT annonce que NASHnext® de Labcorp, basé sur sa technologie diagnostique non invasive NIS4® pour l’identification de la MASH à risque, est lancé via la plateforme « Labcorp OnDemand »
08/06/2026
Labcorp OnDemand facilite l’accès au test NASHnext® dans le cadre d’un parcours de soins piloté par un médecin, pour identifier les patients atteints de MASH « à risque » Cette plateforme élargit l’accès à NASHnext® et [...]
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
08/06/2026
Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturing Intravacc offers state-of-the-art analytical methods for identity, content, [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
08/06/2026
Company announcement – No. 22 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) ( [...]
Xealth Appoints Travis Moore as Chief Revenue Officer
08/06/2026
Health technology veteran brings decades of industry leadership to drive Xealth’s revenue operations SEATTLE, June 08, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and deployment, today [...]
Zealand Pharma - Transactions related to share buy-back program (week 23, 2026)
08/06/2026
Company announcement No. 23 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 23, 2026) Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL [...]
J-Star Holding Announces Successful Annual General Meeting and Reaffirms Commitment to U.S. Advanced Manufacturing Strategy
08/06/2026
TAICHUNG CITY, Taiwan, June 08, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) ("J-Star" or the "Company") today announced the successful completion of its Annual General Meeting, at which shareholders [...]
Vitalic Health survey: Leaders united on need for healthcare affordability, divided on how to fix it
08/06/2026
CHICAGO, June 08, 2026 (GLOBE NEWSWIRE) -- Top healthcare experts across the nation overwhelmingly agree the U.S. healthcare system is financially unsustainable, and every stakeholder must share responsibility for [...]
IBA – ACQUISITION D’ACTIONS PROPRES
08/06/2026
Louvain-la-Neuve, Belgique, 8 juin 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") communique [...]
IBA – ACQUISITION OF OWN SHARES
08/06/2026
Louvain-la-Neuve, Belgium, June 8 th , 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) [...]
GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
08/06/2026
Labcorp OnDemand enables convenient testing with the NASHnext® test, within a physician-directed care pathway to support identification of patients with at-risk MASH This model expands access and supports adoption of [...]
Intravacc Highlights Integrated Analytical Capabilities to Accelerate Vaccine and Biologics Development
08/06/2026
Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturing Intravacc offers state-of-the-art analytical methods for identity, content, [...]
National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada
08/06/2026
HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to address chronic pain among women and women Veterans, outlining a roadmap for a pan- [...]
Appel À Une Action Nationale Pour Lutter Contre La Crise De La Douleur Chronique Chez Les Femmes Et Les Vétéranes Au Canada
08/06/2026
HAMILTON, Ontario, 08 juin 2026 (GLOBE NEWSWIRE) -- Un rapport national récemment publié appelle à une action urgente et coordonnée pour lutter contre la douleur chronique chez les femmes et les vétéranes et présente [...]
Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease
08/06/2026
NORTHSTAR will evaluate the efficacy and safety of investigational oral gildeuretinol, designed to reduce the formation of toxic vitamin A dimers, a proven mechanism of Stargardt disease. The study will assess [...]
Koi Peptides Expands Research Catalog In June 2026
08/06/2026
Wyoming, WY, June 08, 2026 (GLOBE NEWSWIRE) -- Research peptide reference standards in the Koi Peptides laboratory catalog have broadened with the addition of new reference compounds for in vitro analytical use. Each [...]
Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
08/06/2026
First regulatory approval for Sjögren’s disease (SjD) First and only approved therapy for SjD in China Approval based on positive Phase 3 results generated by collaborator RemeGen demonstrating statistically significant [...]
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
08/06/2026
Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission RENO, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq [...]

Pages